Logo (3).png
Cancer Immunotherapy Market Worth $152.83 Billion by 2024 - Exclusive Report by Meticulous Research®
October 30, 2018 09:18 ET | Meticulous Market Research Pvt. Ltd.
LONDON, Oct. 30, 2018 (GLOBE NEWSWIRE) -- According to the latest publication from Meticulous Research®, the global cancer immunotherapy market is expected to grow at a CAGR of 13.8% from 2018 to...
Press Briefing on Recent Clinical and Preclinical Advances in Focused Ultrasound
October 18, 2018 14:24 ET | Focused Ultrasound Foundation
Charlottesville, VA, Oct. 18, 2018 (GLOBE NEWSWIRE) -- WHAT: A briefing featuring key data presented at the 6th International Symposium on Focused Ultrasound, the world's leading forum dedicated to...
UPDATE: Puration Announces Plans To Produce THC Infused Beverage For Legal Canadian Recreational Marijuana Market
May 01, 2018 10:44 ET | Puration, Inc.
DALLAS, May 01, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Puration, Inc. (USOTC:PURA) Today announced plans to produce a THC infused beverage in Canada in conjunction with a previously announced...
Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment
May 01, 2018 09:00 ET | Puration, Inc.
DALLAS, May 01, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Puration, Inc. (USOTC:PURA) Today announced plans to produce a THC infused beverage in Canada in conjunction with a previously announced...
GOVX new logo.png
GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program
January 03, 2018 09:00 ET | GeoVax, Inc.
ATLANTA, GA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is collaborating with Vaxeal Holding SA on...
SBT_New August 2022 LOGO
Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research
July 18, 2017 09:00 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 18, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the Advanta™ Immuno-Oncology Gene Expression Assay, an optimized qPCR...
logo.jpg
Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022: Download Report, Market Opportunity at USD 100 Billion, Clinical Trial Insight by Drug Class
June 26, 2017 04:12 ET | KuicK Research
NEW DELHI, India, June 26, 2017 (GLOBE NEWSWIRE) -- Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022 report highlights: Cancer Immunotherapy Market Assessment by ClassCancer...
Qu Biologics.png
Qu Biologics invited to present Research Data at International Scientific Meetings
May 03, 2017 12:47 ET | Qu Biologics
VANCOUVER, British Columbia, May 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...
Biotherapharma_logo.jpg
Biothera Announces Three Presentations at Upcoming American Association for Cancer Research (AACR) Annual Meeting
March 27, 2017 11:00 ET | Biothera Pharmaceuticals, Inc.
EAGAN, Minn., March 27, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals Inc. announced today that it will present three scientific posters at the American Association for Cancer Research (AACR)...
Biotherapharma_logo.jpg
Biothera Pharmaceuticals’ Phase 2 Study of Imprime PGG Combination Therapy in Non-Small Cell Lung Cancer Patients Published in Investigational New Drugs
March 24, 2017 10:00 ET | Biothera Pharmaceuticals, Inc.
EAGAN, Minn., March 24, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced peer-reviewed publication of results of a randomized Phase 2 clinical study of the Company’s cancer...